FD-001

N/A

Report date: 2025/02/18 16:56:14

NME

Base Information

Drug NameFD-001

Drug Alias NameFD-001

ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue

Mechanisms of ActionEukaryotic peptide chain release factor GTP-binding subunit ERF3A degradersDNA-binding protein Ikaros degradersZinc finger protein Aiolos degraders

TargetsEukaryotic peptide chain release factor GTP-binding subunit ERF3ADNA-binding protein IkarosZinc finger protein Aiolos

Therapy Area/IndicationsHematologic NeoplasmsLymphoma, Non-HodgkinLeukemia, Myeloid, Acute

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesChengdu Fendi Pharmaceutical Co Ltd

China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesChengdu Fendi Pharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsHematologic NeoplasmsLymphoma, Non-HodgkinLeukemia, Myeloid, Acute

Inactive IndicationsN/A

Other Information

ATC CodeN/A